$GRI 3 SEC Filings

Filed On	Filing
25 Apr 2023	Form 3: Chaturvedi Vipin, Chief Scientific Officer No securities owned
25 Apr 2023	Form 3: Simpson Camilla V, Director No securities owned
25 Apr 2023	Form 3: Agro Albert, Chief Medical Officer No securities owned
25 Apr 2023	Form 3: Rongen Roelof, Director No securities owned
25 Apr 2023	Form 3: Hertz Walter Marc, Director No securities owned
24 Apr 2023	Form 3: Szekeres David Leslie, Director No securities owned
09 Mar 2022	Form 3: Chhabra Meenu, Director No securities owned
18 May 2021	Form 3: Kelly Leanne M., Chief Financial Officer No securities owned
10 Feb 2021	Form 3: Payne Joseph E, Director Holds 843,750 shares of Common Stock
10 Feb 2021	Form 3: Arcturus Therapeutics Holdings Inc., 10% owner Holds 843,750 shares of Common Stock
09 Feb 2021	Form 3: Thorell Marella, Director No securities owned
09 Feb 2021	Form 3: Baker David Charles, Director
09 Feb 2021	Form 3: Levi Ofir, Director Holds 196,875 shares of Common Stock
09 Feb 2021	Form 3: Ammer Richard, Director Holds 1,476,734 shares of Common Stock
09 Feb 2021	Form 3: Salmon Pharma GmbH, 10% owner Holds 1,476,734 shares of Common Stock
09 Feb 2021	Form 3: Toren Penny, SVP, Regul Affairs & Prog Mgmt

Comments